Age | n = 330 |
 < 50 | 134 (40.6%) |
 ≥50 | 196 (59.4%) |
Gender | n = 384 |
 Female | 378 (98.4%) |
 Male | 6 (1.6%) |
HIV Status | n = 114 |
 HIV-infected | 49 (42.9%) |
 HIV-uninfected | 65 (57.02%) |
CD4 Count | n = 42 |
 < 250 | 13 (30.9%) |
 250–500 | 17 (40.5%) |
 > 500 | 12 (28.6%) |
TNM Staging | n = 51 |
 Early Stage | 16 (31.4%) |
  Stage I A | 2 (3.9%) |
  Stage I B | 0 (0.0%) |
  Stage II A | 9 (17.7%) |
  Stage II B | 5 (9.8%) |
 Advanced Stage | 35 (68.6%) |
  Stage III A | 23 (45.1%) |
  Stage III B | 10 (19.6%) |
  Stage III C | 2 (3.9%) |